FDA Has Known about Vaccine Shedding for Years and Has Even Issued Guidance on How to Evaluate the Risk
Rhoda Wilson In 2015 the US Food and Drug Administration (“FDA”) issued guidance on how to conduct shedding studies during the preclinical and clinical development of virus or bacteria-based gene therapy products. Shedding, as described by the FDA, is the excretion or release of a product from a vaccinated person’s body. The shed gene therapy […]
An Independent Biosecurity Risk Assessment on the Current Experimental Mass Vaccination Campaign
Jonathan Weissman All the risks listed in the executive summary are described in this risk assessment. Through citing academic experts in internationally recognised peer-reviewed journals or recent preprints, actual pathologies and epidemiological phenomena underpinning these risks are provided. The risks vary in scope from the individual to the entire population. The risks also vary in […]
